Metraipolis › archive › dc_0620f4e91b69
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States — Europe PMC PPR:PPR117009
- Source
- Europe PMC
- Original
- https://europepmc.org/article/PPR/PPR117009
- DOI
- 10.1101/2020.03.09.20032896
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T06:20:26.942Z
- SHA-256 of the archived text
7539a75480669a477719d068dc541873b256aeaa2ca7a9811819401c339543cc- Stable URL of this page
https://metraipolis.com/documento/dc_0620f4e91b69
How to cite
First 12 patients with coronavirus disease 2019 (COVID-19) in the United States — Europe PMC PPR:PPR117009 — Europe PMC, https://europepmc.org/article/PPR/PPR117009 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_0620f4e91b69 (Metraipolis archive dc_0620f4e91b69, sha256 7539a75480669a477719d068dc541873b256aeaa2ca7a9811819401c339543cc)
BibTeX
@misc{dc0620f4e91b69,
title = {First 12 patients with coronavirus disease 2019 (COVID-19) in the United States — Europe PMC PPR:PPR117009},
howpublished = {Europe PMC},
url = {https://europepmc.org/article/PPR/PPR117009},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_0620f4e91b69; sha256 7539a75480669a477719d068dc541873b256aeaa2ca7a9811819401c339543cc},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC, https://europepmc.org/article/PPR/PPR117009. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Introduction: More than 93,000 cases of coronavirus disease (COVID-19) have been reported worldwide. We describe the epidemiology, clinical course, and virologic characteristics of the first 12 U.S. patients with COVID-19. Methods: We collected demographic, exposure, and clinical information from 12 patients confirmed by CDC during January 20–February 5, 2020 to have COVID-19. Respiratory, stool, serum, and urine specimens were submitted for SARS-CoV-2 rRT-PCR testing, virus culture, and whole genome sequencing. Results: Among the 12 patients, median age was 53 years (range: 21–68); 8 were male, 10 had traveled to China, and two were contacts of patients in this series. Commonly reported signs and symptoms at illness onset were fever (n=7) and cough (n=8). Seven patients were hospitalized with radiographic evidence of pneumonia and demonstrated clinical or laboratory signs of worsening during the second week of illness. Three were treated with the investigational antiviral remdesivir. All patients had SARS-CoV-2 RNA detected in respiratory specimens, typically for 2–3 weeks after illness onset, with lowest rRT-PCR Ct values often detected in the first week. SARS-CoV-2 RNA was detected after reported symptom resolution in seven patients. SARS-CoV-2 was cultured from respiratory specimens, and SARS-CoV-2 RNA was detected in stool from 7/10 patients. Conclusions: In 12 patients with mild to moderately severe illness, SARS-CoV-2 RNA and viable virus were detected early, and prolonged RNA detection suggests the window for diagnosis is long. Hospitalized patients showed signs of worsening in the second week after illness onset. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: medRxiv, 2020 (prima pubblicazione 2020-03-12). Identificativi: DOI 10.1101/2020.03.09.20032896. Pagina: https://europepmc.org/article/PPR/PPR117009 — https://doi.org/10.1101/2020.03.09.20032896. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T06:15:14.276Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.